If Australians won’t take the AstraZeneca vaccine, we must donate it to save lives elsewhere, especially while we queue-jump for more Pfizer doses.
Photo by Sharon Seretlo/Gallo Images via Getty Images
South Africa has clearly suffered the consequences of poor strategic decisions to this point. It doesn’t need to continue along these lines.
A shipment of COVID-19 vaccines supplied by COVAX, the vaccine-sharing programme, arriving in Timor Leste.
World leaders have called for an end to the pandemic – but the numbers don’t add up.
A COVID-19 field hospital in Santo Andre, Brazil. The pandemic has killed over 503,000 people in Brazil; just 11% of the population is fully vaccinated.
Mario Tama/Getty Images
The high costs of the world’s colossally unequal COVID-19 immunization rates.
Staff members work at a COVID-19 vaccine-producing plant of Sinovac in Beijing.
Zhang Yuwei/Xinhua via Getty
Local companies in Africa would find it very challenging to be cost-competitive in the longer run when the current worldwide scarcity of COVID-19 vaccines is overcome.
Xinhua / Alamy Stock Photo
Covax was doomed to failure from the start. It is already running into three major problems.
A ground crew member transports the COVID-19 vaccines from COVAX at Bole international airport in Addis Ababa.
Xinhua/Michael Tewelde via Getty Images
The inefficient vaccine allocation rules currently in place must be replaced by new cooperative institutional structures and more concrete steps by the Group of Twenty (G20) countries.
If there ever was a global health system, then it has gone sadly missing when we needed it most.
Scientific knowledge is a critical driver for human health and wellbeing, economic development and environmental sustainability.
Anita Anand, Canada’s minister of public services and procurement, opens a box with some of the first 500,000 of the two million AstraZeneca COVID-19 vaccine doses that Canada secured last March through a deal with the Serum Institute of India.
THE CANADIAN PRESS/Carlos Osorio - POOL
Despite some public virtue signalling, the Canadian government is not doing all it can to improve global access to COVID-19 vaccines. Canada has yet to announce its position on the WTO patent waiver.
Increased demand and falling supplies in India risk leaving many countries empty handed.
The change in the US position signals how clearly the success of every country in fighting the pandemic depends on vaccinating the whole world.
Pfizer and Moderna are expected to make billions in revenue this year. It’s time all vaccine producers share their IP, data and know-how with the rest of the world.
insta_photos/Alamy Stock Photo
New study looks at public attitudes to COVID-19 vaccine aid. The results are reassuring.
Hospital staff in Lagos, Nigeria, administer the AstraZeneca vaccine.
AP Photo/Sunday Alamba
India and South Africa are pressing the World Trade Organization to waive patent rights to help ramp up vaccine production. There’s a better solution.
Paul Hennessy/SOPA Images/LightRocket via Getty Images
The fight for vaccine equity needs to stop looking to multilateral institutions for permission and instead focus on the policy tools that are already available to states.
COVAX, the global vaccine distribution initiative, is well behind its goal of delivering 2 billion doses this year due to under-investment, vaccine nationalism and export restrictions.
A healthcare worker administers an Oxford/AstraZeneca COVID-19 vaccine to her colleague at Mutuini Hospital in Nairobi. Kenya on March 3, 2021.
Photo by Dennis Sigwe/SOPA Images/LightRocket via Getty Images
Kenya grapples with two major challenges in the vaccination rollout: access to sufficient doses in light of the global shortage; and vaccine hesitancy.
Kenya’s health minister Mutahi Kagwe next to the country’s first batch of COVID-19 vaccines at the Jomo Kenyatta International Airport.
Reaching the goals of the plan requires the best possible interaction between public and private -for profit and not-for-profit - healthcare sectors.
Fair global agreements, home-grown vaccines and sharing extra doses with poorer nations are all needed if we’re to ever emerge from this pandemic.